LATEST NEWS

Printed Organic Photovoltaics: S+L Selbstklebeprodukte and OPVIUS sign co-operation

 By developing self-adhesive OPV-films, OPVIUS together with S+L Selbstklebeprodukte GmbH are broadening the horizons for OPV products and OPV integration. Imbedding OPVIUS modules in transparent carrier materials, for example glass or foil membranes, has been possible for some time. Their integration into laminated polycarbonate sheets was recently presented as part of an installation at the Climate-Pavilion at the State Horticultural Show in Thüringen.

The integration techniques developed up until now are mainly aimed at integration, that is to say embedding the module in the carrier material by way of a lamination procedure. This is generally limited to transparent materials and predominantly serves the market for original equipment manufacturers. OPVs can be integrated directly into construction materials whilst they are manufactured, and are therefore installed together with these materials. By developing self-adhesive OPVIUS products, an additional solution can now be provided that will be of interest when retrofitting existing surfaces, as well as for use on non-transparent carrier materials.

S+L Selbstklebeprodukte GmbH’s many years of experience working with stickers for public transport as well as the manufacturing of classic car decals is of central interest to OPVIUS GmbH. Their expertise in various applications, processing procedures, and working with new technologies in the field of foils, all build the foundations of a joint collaboration. Combined with OPVIUS’ production technology and the resulting freedom in terms of colour and form, this expertise will enable users to obtain customised products that are easy to install. This will significantly expand the range of applications of printed organic photovoltaics.

“By developing self-adhesive OPV foils, we can bring our products further into the market, and make them available to an additional user-group. OPVIUS stickers provide many new solutions, particularly for already existing surfaces” says Hermann Issa, Senior Director, Business Development and Sales, OPVIUS. “The need for high quality in order to ensure a good and lasting adhesive bond is frequently underestimated. In this regard, in terms of cooperation, S+L Selbstklebeprodukte GmbH was our first choice for implementation. It has paid off.”

Christian Lins, Business Director of S+L Selbstklebeprodukte GmbH added: “A good adhesion needs to work both visually and flawlessly in terms of function, and needs to last in both indoor and outdoor settings. In addition, we had to look at the properties of the OPVs, and adjust our stickers to the OPVIUS products. Here, our great wealth of experience of adhesion to a large range of substrates, for example trains and buses, paid off, as they also need to be long-lasting and visually perfect under conditions of constant exposure.”

Lihi

Recent Posts

Tower Semiconductor Secures $1.3 Billion Silicon Photonics Agreements and Reports Strong Q1 2026 Growth

Tower Semiconductor announced that it has signed silicon photonics agreements valued at $1.3 billion for…

8 hours ago

14 Israeli Cybersecurity Companies Named to the Rising in Cyber 2026 List of the World’s Most Promising Cyber Startups

The report is based on a survey of 150 CISOs and senior cybersecurity leaders from…

9 hours ago

Sequent Selected by 15 Canadian Municipalities to Deliver Verifiable, Trust-Based Digital Voting for Elections

More than 200,000 voters will cast ballots using a secure and cryptographically verified online voting…

9 hours ago

Sheba and Ichilov Medical Centers Join AccuLine’s International Clinical Trial for AI-Driven Early Heart Attack Risk Assessment

The multi-center study, involving 2,000 patients, will validate the CORA system - a breakthrough AI…

9 hours ago

Molex Completes Acquisition of Teramount Ltd.

Molex, a global electronics leader and connectivity innovator, has completed the acquisition of Teramount Ltd.,…

3 days ago

Immunai Expands Oncology Collaboration, Extending AI-Driven Biomarker and Clinical Insights Through 2027

This agreement marks the third expansion of its collaboration with AstraZeneca, building on collaborations in…

3 days ago